NT-501 is an intraocular implant that contains human cells that have been genetically modified to secrete ciliary neurotrophic factor (CNTF). It is under investigation for the treatment of retinitis pigmentosa and age-related macular degeneration.
Investigated for use/treatment in eye disorders/infections, macular degeneration, and retinal disorders (unspecified).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.